Raymond James & Associates’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.31M Buy
27,436
+3,992
+17% +$615K ﹤0.01% 1757
2024
Q2
$3.53M Buy
23,444
+14,156
+152% +$1.7M ﹤0.01% 1819
2024
Q1
$687K Buy
9,288
+4,695
+102% +$387K ﹤0.01% 2861
2023
Q4
$363K Buy
4,593
+851
+23% +$51.3K ﹤0.01% 3158
2023
Q3
$205K Sell
3,742
-2,079
-36% -$150K ﹤0.01% 3441
2023
Q2
$489K Sell
5,821
-14,457
-71% -$1.11M ﹤0.01% 2955
2023
Q1
$1.54M Buy
20,278
+13,094
+182% +$906K ﹤0.01% 2193
2022
Q4
$443K Buy
7,184
+1,710
+31% +$90.9K ﹤0.01% 2983
2022
Q3
$228K Buy
+5,474
New +$238K ﹤0.01% 3361
2021
Q2
Sell
-8,595
Closed -$357K 4201
2021
Q1
$357K Buy
+8,595
New +$265K ﹤0.01% 3246

Other funds holding TMDX